Do you want to read an article? Please log in or register.
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
Hepatology
Related content
Hepatology
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
J Hepatol
Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, StÄttermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T
doi: 10.1016/j.jhep.2020.10.004
Hepatology
Patient-reported Outcomes (PROs) in Patients with Non-alcoholic Fatty Liver Disease: A Narrative Review of CLDQ-NAFLD/NASH
J Gastroenterol Hepatol.
Yamamura S, Nakano D, Hashida R, Tsutsumi T, Kawaguchi T, Okada M, Isoda H, Takahashi H, Matsuse H, Eguchi Y, Sumida Y, Nakajima A, Gerber L, Younossi ZM, Torimura T
doi: 10.1111/jgh.15172.
Hepatology
Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival
Aliment Pharmacol Ther.
Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V
doi: 10.1111/apt.14627.
Inflammatory Bowel Disease
A simplified definition of histologic improvement in ulcerative colitis and its association with disease outcomes up to 30 weeks from initiation of therapy: Post-hoc analysis of three clinical trials
J Crohns Colitis.
Li K, Strauss R, Marano C, Greenbaum LE, Friedman JR, Peyrin-Biroulet L, Brodmerkel C, De Hertogh G
doi: 10.1093/ecco-jcc/jjz022.
Hepatology
Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
BMC Gastroenterol.
Ngwa T, Orman E, Gomez EV, Vuppalanchi R, Kubal C, Chalasani N, Ghabril M
doi: 10.1186/s12876-019-1155-1.
HepatitisHepatology
ACG Clinical Guideline: Alcoholic Liver Disease
Am J Gastroenterol.
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH
doi: 10.1038/ajg.2017.469.
COMMENTED
Gastrointestinal DiseasesInflammatory Bowel Disease
Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
Clin Gastroenterol Hepatol.
Hu A, Kotze PG, Burgevin A, Tan W, Jess A, Li PS, Kroeker K, Halloran B, Panaccione R, Peyrin-Biroulet L, Ma C, Ananthakrishnan AN
doi: 10.1016/j.cgh.2020.07.012.
HepatitisHepatology
Non-Alcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B
Hepatology.
Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K
doi: 10.1002/hep.30857.
Hepatology
Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation
J Gastroenterol Hepatol.
Grønbaek H, Møller HJ, Saliba F, Zeuzem S, Albillos A, Ariza X, Graupera I, Solà E, Amoros A, Pavesi M, Bossen L, Jalan R, Gines P, Arroyo V, CANONIC investigators, EASL CLIF Consortium.
doi: 10.1111/jgh.15125.